Clinical Trials Browser

NCT06332508 2026-03-13

Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL)

Phase 1 Completed

14 enrolled

Breast

Breast Neoplasms

NCT06802757 2026-02-25

PRISM-TNBC

Phase 2 Recruiting

72 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06443645 2026-02-04

SCARA-B

Recruiting

50 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT07317778 2026-01-05

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Phase 2 Not yet recruiting

249 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT04335669 2025-09-12

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Phase 3 Active not recruiting

325 enrolled

Breast

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02521363 2025-08-22

Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

Phase NA Completed

11 enrolled 7 charts

Breast

Breast Neoplasms

NCT04568161 2025-04-03

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

Phase NA Completed

15 enrolled

Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

NCT02299999 2025-01-15

SAFIR02_Breast

Phase 2 Active not recruiting

1,460 enrolled

Breast

Breast Neoplasms

NCT04109066 2025-01-08

CheckMate 7FL

Phase 3 Completed

521 enrolled 17 charts

Breast

Breast Neoplasms, Neoplasms

NCT06102824 2024-11-25

ORIENTA

Phase 2 Recruiting

252 enrolled

Breast

HER2-negative Breast Cancer

NCT06684054 2024-11-12

STFREiYTNBC

Not yet recruiting

30 enrolled

Breast

Breast Neoplasms

NCT00712881 2024-02-23

Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer

Phase 2 Completed

126 enrolled 16 charts

Breast

Breast Neoplasms

NCT02679040 2023-07-03

HIST-RIC

Phase 2 Unknown

101 enrolled

Breast

Breast Neoplasms

NCT05916755 2023-06-23

PORTRAIT

Recruiting

100 enrolled

Breast

Triple Negative Breast Neoplasms

NCT02549677 2022-10-27

ELEGANT

Phase 4 Completed

294 enrolled

Breast

Breast Neoplasms

NCT01019616 2021-11-29

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Phase 3 Unknown

400 enrolled

Breast

Primary Breast Cancer

NCT02622074 2020-09-10

KEYNOTE 173

Phase 1 Completed

60 enrolled 26 charts

Breast

Parkinson Disease 4, Autosomal Dominant Lewy Body, Triple Negative Breast Neoplasms

NCT04499118 2020-08-05

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Phase 2 Unknown

100 enrolled

Breast

Breast Neoplasms

NCT02561832 2019-02-20

A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer

Phase 1 Terminated

15 enrolled 8 charts

Breast

Breast Neoplasms

NCT00912444 2016-11-22

NATT

Phase 3 Terminated

102 enrolled

Breast

Breast Neoplasms

NCT00352378 2011-06-27

Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer

Phase 3 Completed

209 enrolled

Breast

Breast Neoplasms